1. Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA;
2. Agios Pharmaceuticals, Cambridge, MA;
3. Greenebaum Cancer Center, University of Maryland Medical Center, Baltimore, MD; and
4. Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA